186 related articles for article (PubMed ID: 38017541)
1. Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials.
De Filippo O; D'Ascenzo F; Iannaccone M; Bertaina M; Leone A; Borzillo I; Ravetti E; Solano A; Pagliassotto I; Nebiolo M; Bruno F; Giacobbe F; Muscoli S; Monticone S; Brizzi MF; Biondi Zoccai G; De Ferrari GM
Cardiovasc Diabetol; 2023 Nov; 22(1):324. PubMed ID: 38017541
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and outcomes of Bempedoic acid versus placebo in patients with statin-intolerance: A pilot systematic review and meta-analysis of randomized controlled trials.
Goyal A; Changez MIK; Tariq MD; Mushtaq F; Shamim U; Sohail AH; Mahalwar G
Curr Probl Cardiol; 2024 Feb; 49(2):102236. PubMed ID: 38043880
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy and Safety of Bempedoic Acid in High Cardiovascular Risk Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Uddin N; Syed AA; Ismail SM; Ashraf MT; Khan MK; Sohail A
Curr Probl Cardiol; 2023 Dec; 48(12):102003. PubMed ID: 37516330
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Di Minno A; Lupoli R; Calcaterra I; Poggio P; Forte F; Spadarella G; Ambrosino P; Iannuzzo G; Di Minno MND
J Am Heart Assoc; 2020 Aug; 9(15):e016262. PubMed ID: 32689862
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
Ballantyne CM; Banach M; Mancini GBJ; Lepor NE; Hanselman JC; Zhao X; Leiter LA
Atherosclerosis; 2018 Oct; 277():195-203. PubMed ID: 29910030
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial.
Ray KK; Nicholls SJ; Li N; Louie MJ; Brennan D; Lincoff AM; Nissen SE;
Lancet Diabetes Endocrinol; 2024 Jan; 12(1):19-28. PubMed ID: 38061370
[TBL] [Abstract][Full Text] [Related]
7. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL
JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313
[TBL] [Abstract][Full Text] [Related]
8. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials.
Venkatraman S; Das S; Eerike M; Cherian JJ; Bagepally BS
Eur J Clin Pharmacol; 2023 Nov; 79(11):1453-1463. PubMed ID: 37672112
[TBL] [Abstract][Full Text] [Related]
10. Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial.
Nicholls SJ; Nelson AJ; Lincoff AM; Brennan D; Ray KK; Cho L; Menon V; Li N; Bloedon L; Nissen SE
JAMA Cardiol; 2024 Mar; 9(3):245-253. PubMed ID: 38231501
[TBL] [Abstract][Full Text] [Related]
11. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
Ballantyne CM; Laufs U; Ray KK; Leiter LA; Bays HE; Goldberg AC; Stroes ES; MacDougall D; Zhao X; Catapano AL
Eur J Prev Cardiol; 2020 Apr; 27(6):593-603. PubMed ID: 31357887
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis.
Lin Y; Parco C; Karathanos A; Krieger T; Schulze V; Chernyak N; Icks A; Kelm M; Brockmeyer M; Wolff G
BMJ Open; 2022 Feb; 12(2):e048893. PubMed ID: 35210334
[TBL] [Abstract][Full Text] [Related]
13. Impact of Bempedoic acid on LDL-C reduction and cardiovascular outcomes: A comprehensive meta-analysis of randomized controlled trials.
Del Carpio-Tenorio C; Llerena-Velastegui J; Villacis-Lopez C; Placencia-Silva M; Santander-Fuentes C; Benitez-Acosta K; Sanahuja-Montiel C; Dominguez-Gavilanes D; Carrasco-Perez P; Calderon-Lopez C
Curr Probl Cardiol; 2024 Feb; 49(2):102191. PubMed ID: 37981266
[TBL] [Abstract][Full Text] [Related]
14. Bempedoic Acid and Ezetimibe for the Treatment of Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Phase II/III trials.
Bhagavathula AS; Al Matrooshi NO; Clark CCT; Rahmani J
Clin Drug Investig; 2021 Jan; 41(1):19-28. PubMed ID: 33368025
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
Ray KK; Bays HE; Catapano AL; Lalwani ND; Bloedon LT; Sterling LR; Robinson PL; Ballantyne CM;
N Engl J Med; 2019 Mar; 380(11):1022-1032. PubMed ID: 30865796
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
Laufs U; Ballantyne CM; Banach M; Bays H; Catapano AL; Duell PB; Goldberg AC; Gotto AM; Leiter LA; Ray KK; Bloedon LT; MacDougall D; Zhang Y; Mancini GBJ
J Clin Lipidol; 2022; 16(3):286-297. PubMed ID: 35346603
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials.
Zhao X; Ma X; Luo X; Shi Z; Deng Z; Jin Y; Xiao Z; Tan L; Liu P; Jiang S; Shu Y; Tang B; Qiu C
BMC Pharmacol Toxicol; 2020 Dec; 21(1):86. PubMed ID: 33276805
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis.
Cicero AFG; Fogacci F; Hernandez AV; Banach M;
PLoS Med; 2020 Jul; 17(7):e1003121. PubMed ID: 32673317
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive review of statin-intolerance and the practical application of Bempedoic Acid.
Yarrarapu SNS; Goyal A; Venkata VS; Panchal V; Sivasubramanian BP; Du DT; Jakulla RS; Pamulapati H; Afaq MA; Owens S; Dalia T
J Cardiol; 2024 Jul; 84(1):22-29. PubMed ID: 38521120
[TBL] [Abstract][Full Text] [Related]
20. Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lipoprotein Cholesterol.
Toth PP; Bray S; Villa G; Palagashvili T; Sattar N; Stroes ESG; Worth GM
J Am Heart Assoc; 2022 Sep; 11(18):e025551. PubMed ID: 36073669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
